 | • レポートコード：GIR201105768 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、神経保護剤の世界市場を調査対象にし、神経保護剤の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（脳血管疾患、神経変性疾患、眼科疾患、外傷性中枢神経系損傷）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Genervon Biopharmaceuticals、Neuren Pharmaceuticals、NeuroVive Pharmaceutical、Ceregene、Allon Therapeutics ・メーカー別販売量、売上、市場シェア ・神経保護剤の地域別市場分析 ・神経保護剤の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・神経保護剤のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・神経保護剤のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・神経保護剤の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・神経保護剤の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・神経保護剤の種類別市場規模2015-2020：脳血管疾患、神経変性疾患、眼科疾患、外傷性中枢神経系損傷 ・神経保護剤の用途別市場規模2015-2020：病院、クリニック、その他 ・神経保護剤の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Neuroprotective Agents market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Neuroprotective Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Neuroprotective Agents market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Neuroprotective Agents market has been segmented into
Cerebrovascular Diseases
Neurodegenerative Disorders
Ophthalmic Diseases
Traumatic CNS Injuries
By Application, Neuroprotective Agents has been segmented into:
Hospitals
Clinics
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Neuroprotective Agents market presented in the report. This section sheds light on the sales growth of different regional and country-level Neuroprotective Agents markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Neuroprotective Agents market.
The report offers in-depth assessment of the growth and other aspects of the Neuroprotective Agents market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Neuroprotective Agents Market Share Analysis
Neuroprotective Agents competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Neuroprotective Agents sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Neuroprotective Agents sales, revenue and market share for each player covered in this report.
The major players covered in Neuroprotective Agents are:
Genervon Biopharmaceuticals
Neuren Pharmaceuticals
NeuroVive Pharmaceutical
Ceregene
Allon Therapeutics
Among other players domestic and global, Neuroprotective Agents market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neuroprotective Agents product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neuroprotective Agents, with price, sales, revenue and global market share of Neuroprotective Agents in 2018 and 2019.
Chapter 3, the Neuroprotective Agents competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neuroprotective Agents breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Neuroprotective Agents market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Neuroprotective Agents sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Neuroprotective Agents Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neuroprotective Agents Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Cerebrovascular Diseases
1.2.3 Neurodegenerative Disorders
1.2.4 Ophthalmic Diseases
1.2.5 Traumatic CNS Injuries
1.3 Market Analysis by Application
1.3.1 Overview: Global Neuroprotective Agents Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Overview of Global Neuroprotective Agents Market
1.4.1 Global Neuroprotective Agents Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Genervon Biopharmaceuticals
2.1.1 Genervon Biopharmaceuticals Details
2.1.2 Genervon Biopharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Genervon Biopharmaceuticals SWOT Analysis
2.1.4 Genervon Biopharmaceuticals Product and Services
2.1.5 Genervon Biopharmaceuticals Neuroprotective Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Neuren Pharmaceuticals
2.2.1 Neuren Pharmaceuticals Details
2.2.2 Neuren Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Neuren Pharmaceuticals SWOT Analysis
2.2.4 Neuren Pharmaceuticals Product and Services
2.2.5 Neuren Pharmaceuticals Neuroprotective Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 NeuroVive Pharmaceutical
2.3.1 NeuroVive Pharmaceutical Details
2.3.2 NeuroVive Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 NeuroVive Pharmaceutical SWOT Analysis
2.3.4 NeuroVive Pharmaceutical Product and Services
2.3.5 NeuroVive Pharmaceutical Neuroprotective Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Ceregene
2.4.1 Ceregene Details
2.4.2 Ceregene Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Ceregene SWOT Analysis
2.4.4 Ceregene Product and Services
2.4.5 Ceregene Neuroprotective Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Allon Therapeutics
2.5.1 Allon Therapeutics Details
2.5.2 Allon Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Allon Therapeutics SWOT Analysis
2.5.4 Allon Therapeutics Product and Services
2.5.5 Allon Therapeutics Neuroprotective Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Neuroprotective Agents Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Neuroprotective Agents Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Neuroprotective Agents Manufacturer Market Share in 2019
3.3.2 Top 6 Neuroprotective Agents Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Neuroprotective Agents Sales, Revenue and Market Share by Regions
4.1.1 Global Neuroprotective Agents Sales and Market Share by Regions (2015-2020)
4.1.2 Global Neuroprotective Agents Revenue and Market Share by Regions (2015-2020)
4.2 North America Neuroprotective Agents Sales and Growth Rate (2015-2020)
4.3 Europe Neuroprotective Agents Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Neuroprotective Agents Sales and Growth Rate (2015-2020)
4.5 South America Neuroprotective Agents Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Neuroprotective Agents Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Neuroprotective Agents Sales, Revenue and Market Share by Country
5.1.1 North America Neuroprotective Agents Sales and Market Share by Country (2015-2020)
5.1.2 North America Neuroprotective Agents Revenue and Market Share by Country (2015-2020)
5.2 United States Neuroprotective Agents Sales and Growth Rate (2015-2020)
5.3 Canada Neuroprotective Agents Sales and Growth Rate (2015-2020)
5.4 Mexico Neuroprotective Agents Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Neuroprotective Agents Sales, Revenue and Market Share by Country
6.1.1 Europe Neuroprotective Agents Sales and Market Share by Country (2015-2020)
6.1.2 Europe Neuroprotective Agents Revenue and Market Share by Country (2015-2020)
6.2 Germany Neuroprotective Agents Sales and Growth Rate (2015-2020)
6.3 UK Neuroprotective Agents Sales and Growth Rate (2015-2020)
6.4 France Neuroprotective Agents Sales and Growth Rate (2015-2020)
6.5 Russia Neuroprotective Agents Sales and Growth Rate (2015-2020)
6.6 Italy Neuroprotective Agents Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Neuroprotective Agents Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Neuroprotective Agents Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Neuroprotective Agents Revenue and Market Share by Regions (2015-2020)
7.2 China Neuroprotective Agents Sales and Growth Rate (2015-2020)
7.3 Japan Neuroprotective Agents Sales and Growth Rate (2015-2020)
7.4 Korea Neuroprotective Agents Sales and Growth Rate (2015-2020)
7.5 India Neuroprotective Agents Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Neuroprotective Agents Sales and Growth Rate (2015-2020)
7.7 Australia Neuroprotective Agents Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Neuroprotective Agents Sales, Revenue and Market Share by Country
8.1.1 South America Neuroprotective Agents Sales and Market Share by Country (2015-2020)
8.1.2 South America Neuroprotective Agents Revenue and Market Share by Country (2015-2020)
8.2 Brazil Neuroprotective Agents Sales and Growth Rate (2015-2020)
8.3 Argentina Neuroprotective Agents Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Neuroprotective Agents Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Neuroprotective Agents Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Neuroprotective Agents Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Neuroprotective Agents Sales and Growth Rate (2015-2020)
9.3 Turkey Neuroprotective Agents Sales and Growth Rate (2015-2020)
9.4 Egypt Neuroprotective Agents Sales and Growth Rate (2015-2020)
9.5 South Africa Neuroprotective Agents Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Neuroprotective Agents Sales and Market Share by Type (2015-2020)
10.2 Global Neuroprotective Agents Revenue and Market Share by Type (2015-2020)
10.3 Global Neuroprotective Agents Price by Type (2015-2020)
11 Global Neuroprotective Agents Market Segment by Application
11.1 Global Neuroprotective Agents Sales Market Share by Application (2015-2020)
11.2 Global Neuroprotective Agents Revenue Market Share by Application (2015-2020)
11.3 Global Neuroprotective Agents Price by Application (2015-2020)
12 Market Forecast
12.1 Global Neuroprotective Agents Sales, Revenue and Growth Rate (2021-2025)
12.2 Neuroprotective Agents Market Forecast by Regions (2021-2025)
12.2.1 North America Neuroprotective Agents Market Forecast (2021-2025)
12.2.2 Europe Neuroprotective Agents Market Forecast (2021-2025)
12.2.3 Asia-Pacific Neuroprotective Agents Market Forecast (2021-2025)
12.2.4 South America Neuroprotective Agents Market Forecast (2021-2025)
12.2.5 Middle East & Africa Neuroprotective Agents Market Forecast (2021-2025)
12.3 Neuroprotective Agents Market Forecast by Type (2021-2025)
12.3.1 Global Neuroprotective Agents Sales Forecast by Type (2021-2025)
12.3.2 Global Neuroprotective Agents Market Share Forecast by Type (2021-2025)
12.4 Neuroprotective Agents Market Forecast by Application (2021-2025)
12.4.1 Global Neuroprotective Agents Sales Forecast by Application (2021-2025)
12.4.2 Global Neuroprotective Agents Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Neuroprotective Agents Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Neuroprotective Agents by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Neuroprotective Agents Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Genervon Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Genervon Biopharmaceuticals Neuroprotective Agents Major Business
Table 9. Genervon Biopharmaceuticals Neuroprotective Agents Total Revenue (USD Million) (2018-2019)
Table 10. Genervon Biopharmaceuticals SWOT Analysis
Table 11. Genervon Biopharmaceuticals Neuroprotective Agents Product and Services
Table 12. Genervon Biopharmaceuticals Neuroprotective Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Neuren Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Neuren Pharmaceuticals Neuroprotective Agents Major Business
Table 15. Neuren Pharmaceuticals Neuroprotective Agents Total Revenue (USD Million) (2018-2019)
Table 16. Neuren Pharmaceuticals SWOT Analysis
Table 17. Neuren Pharmaceuticals Neuroprotective Agents Product and Services
Table 18. Neuren Pharmaceuticals Neuroprotective Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. NeuroVive Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. NeuroVive Pharmaceutical Neuroprotective Agents Major Business
Table 21. NeuroVive Pharmaceutical Neuroprotective Agents Total Revenue (USD Million) (2018-2019)
Table 22. NeuroVive Pharmaceutical SWOT Analysis
Table 23. NeuroVive Pharmaceutical Neuroprotective Agents Product and Services
Table 24. NeuroVive Pharmaceutical Neuroprotective Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Ceregene Basic Information, Manufacturing Base and Competitors
Table 26. Ceregene Neuroprotective Agents Major Business
Table 27. Ceregene Neuroprotective Agents Total Revenue (USD Million) (2018-2019)
Table 28. Ceregene SWOT Analysis
Table 29. Ceregene Neuroprotective Agents Product and Services
Table 30. Ceregene Neuroprotective Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Allon Therapeutics Basic Information, Manufacturing Base and Competitors
Table 32. Allon Therapeutics Neuroprotective Agents Major Business
Table 33. Allon Therapeutics Neuroprotective Agents Total Revenue (USD Million) (2018-2019)
Table 34. Allon Therapeutics SWOT Analysis
Table 35. Allon Therapeutics Neuroprotective Agents Product and Services
Table 36. Allon Therapeutics Neuroprotective Agents Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Neuroprotective Agents Sales by Manufacturer (2018-2019) (K MT)
Table 38. Global Neuroprotective Agents Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Neuroprotective Agents Sales by Regions (2015-2020) (K MT)
Table 40. Global Neuroprotective Agents Sales Market Share by Regions (2015-2020)
Table 41. Global Neuroprotective Agents Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Neuroprotective Agents Sales by Countries (2015-2020) (K MT)
Table 43. North America Neuroprotective Agents Sales Market Share by Countries (2015-2020)
Table 44. North America Neuroprotective Agents Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Neuroprotective Agents Revenue Market Share by Countries (2015-2020)
Table 46. Europe Neuroprotective Agents Sales by Countries (2015-2020) (K MT)
Table 47. Europe Neuroprotective Agents Sales Market Share by Countries (2015-2020)
Table 48. Europe Neuroprotective Agents Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Neuroprotective Agents Sales by Regions (2015-2020) (K MT)
Table 50. Asia-Pacific Neuroprotective Agents Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Neuroprotective Agents Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Neuroprotective Agents Sales by Countries (2015-2020) (K MT)
Table 53. South America Neuroprotective Agents Sales Market Share by Countries (2015-2020)
Table 54. South America Neuroprotective Agents Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Neuroprotective Agents Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Neuroprotective Agents Sales by Countries (2015-2020) (K MT)
Table 57. Middle East & Africa Neuroprotective Agents Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Neuroprotective Agents Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Neuroprotective Agents Revenue Market Share by Countries (2015-2020)
Table 60. Global Neuroprotective Agents Sales by Type (2015-2020) (K MT)
Table 61. Global Neuroprotective Agents Sales Share by Type (2015-2020)
Table 62. Global Neuroprotective Agents Revenue by Type (2015-2020) (USD Million)
Table 63. Global Neuroprotective Agents Revenue Share by Type (2015-2020)
Table 64. Global Neuroprotective Agents Sales by Application (2015-2020) (K MT)
Table 65. Global Neuroprotective Agents Sales Share by Application (2015-2020)
Table 66. Global Neuroprotective Agents Sales Forecast by Regions (2021-2025) (K MT)
Table 67. Global Neuroprotective Agents Market Share Forecast by Regions (2021-2025)
Table 68. Global Neuroprotective Agents Sales Forecast by Type (2021-2025) (K MT)
Table 69. Global Neuroprotective Agents Market Share Forecast by Type (2021-2025)
Table 70. Global Neuroprotective Agents Sales Forecast by Application (2021-2025)
Table 71. Global Neuroprotective Agents Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Neuroprotective Agents Picture
Figure 2. Global Sales Market Share of Neuroprotective Agents by Type in 2019
Figure 3. Cerebrovascular Diseases Picture
Figure 4. Neurodegenerative Disorders Picture
Figure 5. Ophthalmic Diseases Picture
Figure 6. Traumatic CNS Injuries Picture
Figure 7. Neuroprotective Agents Sales Market Share by Application in 2018
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Others Picture
Figure 11. Global Neuroprotective Agents Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Neuroprotective Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Neuroprotective Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Neuroprotective Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Neuroprotective Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Neuroprotective Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Neuroprotective Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Neuroprotective Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Neuroprotective Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Neuroprotective Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Neuroprotective Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Neuroprotective Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Neuroprotective Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Neuroprotective Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Neuroprotective Agents Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Neuroprotective Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Neuroprotective Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Neuroprotective Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Neuroprotective Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Neuroprotective Agents Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Neuroprotective Agents Sales Market Share by Manufacturer in 2019
Figure 32. Global Neuroprotective Agents Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Neuroprotective Agents Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Neuroprotective Agents Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Neuroprotective Agents Sales and Growth Rate (2015-2020) (K MT)
Figure 37. Global Neuroprotective Agents Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Neuroprotective Agents Revenue Market Share by Regions (2015-2020)
Figure 39. Global Neuroprotective Agents Revenue Market Share by Regions in 2018
Figure 40. North America Neuroprotective Agents Sales and Growth Rate (2015-2020)
Figure 41. Europe Neuroprotective Agents Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Neuroprotective Agents Sales and Growth Rate (2015-2020)
Figure 43. South America Neuroprotective Agents Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Neuroprotective Agents Sales and Growth Rate (2015-2020)
Figure 45. North America Neuroprotective Agents Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Neuroprotective Agents Sales Market Share by Countries (2015-2020)
Figure 47. North America Neuroprotective Agents Sales Market Share by Countries in 2018
Figure 48. North America Neuroprotective Agents Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Neuroprotective Agents Revenue Market Share by Countries in 2018
Figure 50. United States Neuroprotective Agents Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Canada Neuroprotective Agents Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Mexico Neuroprotective Agents Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Europe Neuroprotective Agents Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Neuroprotective Agents Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Neuroprotective Agents Revenue Market Share by Countries in 2019
Figure 56. Germany Neuroprotective Agents Sales and Growth Rate (2015-2020) (K MT)
Figure 57. UK Neuroprotective Agents Sales and Growth Rate (2015-2020) (K MT)
Figure 58. France Neuroprotective Agents Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Russia Neuroprotective Agents Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Italy Neuroprotective Agents Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Asia-Pacific Neuroprotective Agents Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Neuroprotective Agents Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Neuroprotective Agents Revenue Market Share by Regions 2019
Figure 64. China Neuroprotective Agents Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Japan Neuroprotective Agents Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Korea Neuroprotective Agents Sales and Growth Rate (2015-2020) (K MT)
Figure 67. India Neuroprotective Agents Sales and Growth Rate (2015-2020) (K MT)
Figure 68. Southeast Asia Neuroprotective Agents Sales and Growth Rate (2015-2020) (K MT)
Figure 69. South America Neuroprotective Agents Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Neuroprotective Agents Sales Market Share by Countries in 2019
Figure 71. South America Neuroprotective Agents Revenue Market Share by Countries in 2019
Figure 72. Brazil Neuroprotective Agents Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Argentina Neuroprotective Agents Sales and Growth Rate (2015-2020) (K MT)
Figure 74. Middle East and Africa Neuroprotective Agents Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Neuroprotective Agents Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Neuroprotective Agents Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Neuroprotective Agents Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Neuroprotective Agents Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Egypt Neuroprotective Agents Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Turkey Neuroprotective Agents Sales and Growth Rate (2015-2020) (K MT)
Figure 81. South Africa Neuroprotective Agents Sales and Growth Rate (2015-2020) (K MT)
Figure 82. Global Neuroprotective Agents Sales and Growth Rate (2021-2025) (K MT)
Figure 83. Global Neuroprotective Agents Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Neuroprotective Agents Market Forecast (2021-2025) (K MT)
Figure 85. Europe Sales Neuroprotective Agents Market Forecast (2021-2025) (K MT)
Figure 86. Asia-Pacific Sales Neuroprotective Agents Market Forecast (2021-2025) (K MT)
Figure 87. South America Sales Neuroprotective Agents Market Forecast (2021-2025) (K MT)
Figure 88. Middle East & Africa Sales Neuroprotective Agents Market Forecast (2021-2025) (K MT)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
歯科用接着剤の世界市場 2020年 Market Overview The Dental Bonding Agents and Adhesives market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…- 造影剤の世界市場 2020年 Market Overview The Contrast Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- グリーンキレート（天然キレート剤）の世界市場 2020年 Market Overview The Green Chelates (Natural Chelating Agents) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value…
- 核剤・清澄剤の世界市場 2020年 Market Overview The global Nucleating and Clarifying Agents market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.8% in the forecast period of 2020 to 2025 and will expected to reach USD 866 million by 2025, from USD 745.2 million in 2019. The Nucleat…
- 塞栓剤の世界市場 2020年 Market Overview The global Embolic Agents market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Embolic Agents market report p…